1st Quarter - Report

OGR for AMGEN USA INC

Period 1st Quarter 2010 Filed Apr 19, 2010 Signed by Amy Allman, Chief Administrative Officer

Official filing
Firm
OGR
Client
AMGEN USA INC
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to international tax reform.

LobbyistCovered position, as disclosed
DEAN AGUILLEN —

Contacted: HOUSE OF REPRESENTATIVES

Health Issues HCR

H.R.1548, Pathway for Biosimilars Act, FDA related issues. H.R.3590, Patient Protection and Affordable Care Act, H.R.4872, Health Care and Education Reconciliation Act of 2010, healthcare issues.

LobbyistCovered position, as disclosed
DEAN AGUILLEN —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 4872 (111th), H.R. 3590 (111th), H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.